Sophia Genetics Sa Stock Performance
| SOPH Stock | USD 4.50 0.07 1.53% |
The entity has a beta of 1.49, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Sophia Genetics will likely underperform. At this point, Sophia Genetics SA has a negative expected return of -0.0802%. Please make sure to validate Sophia Genetics' value at risk, as well as the relationship between the skewness and day median price , to decide if Sophia Genetics SA performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Sophia Genetics SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Sophia Genetics is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders. ...more
Actual Historical Performance (%)
One Day Return (1.53) | Five Day Return (7.22) | Year To Date Return (3.64) | Ten Year Return (73.15) | All Time Return (73.15) |
1 | 3 Promising Penny Stocks With Under 2B Market Cap | 12/31/2025 |
2 | Sophon 24 Hour Volume Reaches 36.13 Million | 01/08/2026 |
3 | SOPHiA GENETICS verstrekt voorlopige financile resultaten voor het vierde kwartaal en het volledige jaar 2025, geeft richtsnoeren voor 2026 en kondigt overgangs... | 01/12/2026 |
4 | SOPHiA GENETICS Expands Perceptive Credit Facility With New 25 Million Term Loan Capacity and Additional Warrants - TipRanks | 01/28/2026 |
5 | SOPHiA GENETICS SA Sees Significant Increase in Short Interest | 02/02/2026 |
6 | Sophon Tops 24 Hour Volume of 26.18 Million | 02/09/2026 |
7 | SOPHiA GENETICS Projected to Announce Earnings on Tuesday - MarketBeat | 02/24/2026 |
| Begin Period Cash Flow | 123.3 M | |
| Total Cashflows From Investing Activities | -8.2 M |
Sophia Genetics Relative Risk vs. Return Landscape
If you would invest 484.00 in Sophia Genetics SA on November 30, 2025 and sell it today you would lose (34.00) from holding Sophia Genetics SA or give up 7.02% of portfolio value over 90 days. Sophia Genetics SA is currently does not generate positive expected returns and assumes 2.8146% risk (volatility on return distribution) over the 90 days horizon. In different words, 25% of stocks are less volatile than Sophia, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Sophia Genetics Target Price Odds to finish over Current Price
The tendency of Sophia Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 4.50 | 90 days | 4.50 | more than 93.0 |
Based on a normal probability distribution, the odds of Sophia Genetics to move above the current price in 90 days from now is more than 93.0 (This Sophia Genetics SA probability density function shows the probability of Sophia Stock to fall within a particular range of prices over 90 days) .
Sophia Genetics Price Density |
| Price |
Predictive Modules for Sophia Genetics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sophia Genetics SA. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophia Genetics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Sophia Genetics is not an exception. The market had few large corrections towards the Sophia Genetics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Sophia Genetics SA, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Sophia Genetics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.1 | |
β | Beta against Dow Jones | 1.49 | |
σ | Overall volatility | 0.26 | |
Ir | Information ratio | -0.02 |
Sophia Genetics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Sophia Genetics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Sophia Genetics SA can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Sophia Genetics SA generated a negative expected return over the last 90 days | |
| Sophia Genetics SA has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 65.17 M. Net Loss for the year was (61.27 M) with profit before overhead, payroll, taxes, and interest of 49.49 M. | |
| Sophia Genetics SA currently holds about 216.61 M in cash with (42.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.38. | |
| Sophia Genetics SA has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: SOPHiA GENETICS Projected to Announce Earnings on Tuesday - MarketBeat |
Sophia Genetics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Sophia Stock often depends not only on the future outlook of the current and potential Sophia Genetics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sophia Genetics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 65.8 M | |
| Cash And Short Term Investments | 80.2 M |
Sophia Genetics Fundamentals Growth
Sophia Stock prices reflect investors' perceptions of the future prospects and financial health of Sophia Genetics, and Sophia Genetics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sophia Stock performance.
| Return On Equity | -0.86 | ||||
| Return On Asset | -0.26 | ||||
| Profit Margin | (1.02) % | ||||
| Operating Margin | (0.92) % | ||||
| Current Valuation | 271.07 M | ||||
| Shares Outstanding | 67.85 M | ||||
| Price To Book | 3.94 X | ||||
| Price To Sales | 4.23 X | ||||
| Revenue | 65.17 M | ||||
| Gross Profit | 49.49 M | ||||
| EBITDA | (50.76 M) | ||||
| Net Income | (61.27 M) | ||||
| Cash And Equivalents | 216.61 M | ||||
| Cash Per Share | 3.38 X | ||||
| Total Debt | 30.03 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 7.58 X | ||||
| Book Value Per Share | 0.89 X | ||||
| Cash Flow From Operations | (42.82 M) | ||||
| Earnings Per Share | (1.12) X | ||||
| Market Capitalization | 310.06 M | ||||
| Total Asset | 155.31 M | ||||
| Retained Earnings | (440.28 M) | ||||
| Working Capital | 72.6 M | ||||
About Sophia Genetics Performance
By evaluating Sophia Genetics' fundamental ratios, stakeholders can gain valuable insights into Sophia Genetics' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Sophia Genetics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Sophia Genetics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 115.99 | 140.34 | |
| Return On Tangible Assets | (0.45) | (0.47) | |
| Return On Capital Employed | (0.47) | (0.49) | |
| Return On Assets | (0.36) | (0.38) | |
| Return On Equity | (0.58) | (0.61) |
Things to note about Sophia Genetics SA performance evaluation
Checking the ongoing alerts about Sophia Genetics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Sophia Genetics SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Sophia Genetics SA generated a negative expected return over the last 90 days | |
| Sophia Genetics SA has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 65.17 M. Net Loss for the year was (61.27 M) with profit before overhead, payroll, taxes, and interest of 49.49 M. | |
| Sophia Genetics SA currently holds about 216.61 M in cash with (42.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.38. | |
| Sophia Genetics SA has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: SOPHiA GENETICS Projected to Announce Earnings on Tuesday - MarketBeat |
- Analyzing Sophia Genetics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sophia Genetics' stock is overvalued or undervalued compared to its peers.
- Examining Sophia Genetics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Sophia Genetics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sophia Genetics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Sophia Genetics' stock. These opinions can provide insight into Sophia Genetics' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Sophia Stock analysis
When running Sophia Genetics' price analysis, check to measure Sophia Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sophia Genetics is operating at the current time. Most of Sophia Genetics' value examination focuses on studying past and present price action to predict the probability of Sophia Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sophia Genetics' price. Additionally, you may evaluate how the addition of Sophia Genetics to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |